Form 4/A for OPK OPKO HEALTH, INC.
Accepted 2022-05-13 00:00:00 ET · period of report 2022-05-09 · accession 0001209191-22-028956 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2022-05-13 | 2022-05-09 | OPK | Borisy Alexis | Dir | A - Grant | $0.00 | +312.6K | 312.6K | New | $0 |
| DA | 2022-05-13 | 2022-05-09 | OPK | Borisy Alexis | Dir | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-09 | A | A | 312,612 | $0.00 | 312,612 | D | — | — | (F1) On May 9, 2022, the Issuer awarded the Reporting Person restricted stock in the amount indicated in connection with the merger between the Issuer and ModeX Therapeutics, Inc. ("ModeX"), pursuant to which ModeX became a subsidiary of the Issuer. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-05-09 | A | A | 50,000 | $0.00 | 50,000 | D | $2.44 · 2023-05-09 to 2032-05-08 | 50,000 Common Stock |